PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies10.1016/b978-0-12-819937-4.09990-82020ivCopyrighthttps://api.elsevier.com/content/article/PII:B9780128199374099908?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128199374099908?httpAccept=text/plain
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies10.1016/b978-0-12-819937-4.09985-42020213-219Indexhttps://api.elsevier.com/content/article/PII:B9780128199374099854?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128199374099854?httpAccept=text/plain
Insulin Resistance - Evolving Concepts and Treatment Strategies [Working Title]10.5772/intechopen.1048062022Molecular Mechanisms Involved in Insulin Resistance: Recent Updates and Future ChallengesAtamjit Singh, Nikhita Ghai, PreetMohinder Singh Bedihttp://www.intechopen.com/download/pdf/82197
Drug Discovery Today: Therapeutic Strategies10.1016/j.ddstr.2005.05.024200522125-128Stearoyl-CoA desaturase: A therapeutic target of insulin resistance and diabetesAgnieszka Dobrzyn, James Ntambihttps://api.elsevier.com/content/article/PII:S1740677305000288?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1740677305000288?httpAccept=text/plain
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies10.1016/b978-0-12-819937-4.09987-82020i-iiiFront Matterhttps://api.elsevier.com/content/article/PII:B9780128199374099878?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128199374099878?httpAccept=text/plain
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies10.1016/b978-0-12-819937-4.09993-32020xiAbout the Editorshttps://api.elsevier.com/content/article/PII:B9780128199374099933?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128199374099933?httpAccept=text/plain
Drug Discovery Today: Therapeutic Strategies10.1016/j.ddstr.2005.04.002200522105-110Targeting protein kinase C epsilon or theta as a therapeutic strategy for insulin resistanceCarsten Schmitz-Peifferhttps://api.elsevier.com/content/article/PII:S1740677305000033?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1740677305000033?httpAccept=text/plain
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies10.1016/b978-0-12-819937-4.09994-52020viiAbout the Series Editorhttps://api.elsevier.com/content/article/PII:B9780128199374099945?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128199374099945?httpAccept=text/plain
Diabetes & Metabolism Journal10.4093/dmj.2021.0280202246115-37Insulin Resistance: From Mechanisms to Therapeutic StrategiesShin-Hae Lee, Shi-Young Park, Cheol Soo Choihttp://e-dmj.org/upload/pdf/dmj-2021-0280.pdf, http://e-dmj.org/journal/view.php?doi=10.4093/dmj.2021.0280, http://e-dmj.org/upload/pdf/dmj-2021-0280.pdf
Drug Resistance in Colorectal Cancer: Molecular Mechanisms and Therapeutic Strategies10.1016/b978-0-12-819937-4.00001-720201-33Drug resistance in colorectal cancer: General aspectsGodefridus J. Petershttps://api.elsevier.com/content/article/PII:B9780128199374000017?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128199374000017?httpAccept=text/plain